Patient
SITE009-0081
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE009 (AUS) (Dr. Novak)
consented 2025-12-05
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 3
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-01-05 (study day 212); relationship: NOT RELATED
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-12-12 (study day 188); relationship: not assessed
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-06-18 (study day 11); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.